Fine-Tuning the Nanostructured Titanium Oxide Surface for Selective Biological Response.
Niharika RawatMetka BenčinaDomen PaulJanez KovačKatja LakotaPolona ŽigonVeronika Kralj-IgličHsin-Chia HoMarija VukomanovićAleš IgličIta JunkarPublished in: ACS applied bio materials (2023)
Cardiovascular diseases are a pre-eminent global cause of mortality in the modern world. Typically, surgical intervention with implantable medical devices such as cardiovascular stents is deployed to reinstate unobstructed blood flow. Unfortunately, existing stent materials frequently induce restenosis and thrombosis, necessitating the development of superior biomaterials. These biomaterials should inhibit platelet adhesion (mitigating stent-induced thrombosis) and smooth muscle cell proliferation (minimizing restenosis) while enhancing endothelial cell proliferation at the same time. To optimize the surface properties of Ti 6 Al 4 V medical implants, we investigated two surface treatment procedures: gaseous plasma treatment and hydrothermal treatment. We analyzed these modified surfaces through scanning electron microscopy (SEM), water contact angle analysis (WCA), X-ray photoelectron spectroscopy (XPS), and X-ray diffraction (XRD) analysis. Additionally, we assessed in vitro biological responses, including platelet adhesion and activation, as well as endothelial and smooth muscle cell proliferation. Herein, we report the influence of pre/post oxygen plasma treatment on titanium oxide layer formation via a hydrothermal technique. Our results indicate that alterations in the titanium oxide layer and surface nanotopography significantly influence cell interactions. This work offers promising insights into designing multifunctional biomaterial surfaces that selectively promote specific cell types' proliferation─which is a crucial advancement in next-generation vascular implants.
Keyphrases
- cell proliferation
- smooth muscle
- electron microscopy
- high resolution
- healthcare
- cardiovascular disease
- randomized controlled trial
- pulmonary embolism
- cell cycle
- coronary artery disease
- risk assessment
- biofilm formation
- staphylococcus aureus
- escherichia coli
- cell therapy
- metabolic syndrome
- drug delivery
- risk factors
- single cell
- computed tomography
- cardiovascular events
- cancer therapy
- mesenchymal stem cells
- cardiovascular risk factors
- bone regeneration
- soft tissue
- candida albicans
- oxide nanoparticles